157 related articles for article (PubMed ID: 11540313)
1. Anabolic effects of fluoride on bone.
Pak CY; Zerwekh JE; Antich P
Trends Endocrinol Metab; 1995 Sep; 6(7):229-34. PubMed ID: 11540313
[TBL] [Abstract][Full Text] [Related]
2. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
Zerwekh JE; Padalino P; Pak CY
Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
[TBL] [Abstract][Full Text] [Related]
3. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
[TBL] [Abstract][Full Text] [Related]
5. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
[TBL] [Abstract][Full Text] [Related]
6. Reductions in bone strength after fluoride treatment are not reflected in tissue-level acoustic measurements.
Antich PP; Pak C; Zerwekh J
Bone; 1997 Aug; 21(2):207-8. PubMed ID: 9267697
[No Abstract] [Full Text] [Related]
7. Sodium fluoride therapy of postmenopausal osteoporosis.
Kleerekoper M; Mendlovic DB
Endocr Rev; 1993 Jun; 14(3):312-23. PubMed ID: 8319597
[TBL] [Abstract][Full Text] [Related]
8. [Problems of high dose sodium fluoride treatment in osteoporosis. 2. The effect of fluorides on the human skeleton].
Heidelmann G
Z Arztl Fortbild (Jena); 1979 Jun; 73(11):526-9. PubMed ID: 473799
[No Abstract] [Full Text] [Related]
9. Effect of intermittent therapy with a slow-release fluoride preparation.
Pak CY; Sakhaee K; Zerwekh JE
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
[TBL] [Abstract][Full Text] [Related]
10. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
[TBL] [Abstract][Full Text] [Related]
11. Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
Antich PP; Pak CY; Gonzales J; Anderson J; Sakhaee K; Rubin C
J Bone Miner Res; 1993 Mar; 8(3):301-11. PubMed ID: 8456586
[TBL] [Abstract][Full Text] [Related]
12. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
[TBL] [Abstract][Full Text] [Related]
13. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
[TBL] [Abstract][Full Text] [Related]
14. Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone.
Zerwekh JE; Antich PP; Sakhaee K; Gonzales J; Gottschalk F; Pak CY
J Bone Miner Res; 1991 Mar; 6(3):239-44. PubMed ID: 2035350
[TBL] [Abstract][Full Text] [Related]
15. No bones about fluoride.
Mundy GR
Nat Med; 1995 Nov; 1(11):1130-1. PubMed ID: 7584977
[TBL] [Abstract][Full Text] [Related]
16. Fluoride and the FDA: a curious case.
Turner CH
J Bone Miner Res; 1996 Sep; 11(9):1369-71. PubMed ID: 8864913
[No Abstract] [Full Text] [Related]
17. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.
Murray TM; Ste-Marie LG
CMAJ; 1996 Oct; 155(7):949-54. PubMed ID: 8837545
[TBL] [Abstract][Full Text] [Related]
18. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
[TBL] [Abstract][Full Text] [Related]
19. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY
Bone; 1994; 15(6):691-9. PubMed ID: 7873299
[TBL] [Abstract][Full Text] [Related]
20. Water fluoridation and osteoporotic fracture.
Hillier S; Inskip H; Coggon D; Cooper C
Community Dent Health; 1996 Sep; 13 Suppl 2():63-8. PubMed ID: 8897754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
